Page 131 - 南京医科大学学报自然科学版
P. 131
第41卷第11期 谭 磊,陈明月,沈 彬. 基因编辑研究进展与展望[J].
2021年11月 南京医科大学学报(自然科学版),2021,41(11):1689-1694 ·1693 ·
genome⁃targeting scope and precision of base editing with ing[J]. Nat Biotechnol,2015,33(7):755-760
engineered Cas9⁃cytidine deaminase fusions[J]. Nat Bio⁃ [38] KAWANO F,SUZUKI H,FURUYA A,et al. Engineered
technol,2017,35(4):371-376 pairs of distinct photoswitches for optogenetic control of
[23] LIU Z,CHEN S,SHAN H,et al. Efficient base editing cellular proteins[J]. Nat Commun,2015,6:6256
with high precision in rabbits using YFE ⁃ BE4max[J]. [39] ZHANG Y,LING X,SU X,et al. Optical control of a
Cell Death Dis,2020,11(1):36 CRISPR/Cas9 system for gene editing by using photola⁃
[24] GRÜNEWALD J,ZHOU R,IYER S,et al. CRISPR DNA bile crRNA[J]. Angew Chem Int Ed Engl,2020,59(47):
base editors with reduced RNA off⁃target and self⁃editing 20895-20899
activities[J]. Nat Biotechnol,2019,37(9):1041-1048 [40] MAJI B,GANGOPADHYAY S A,LEE M,et al. A high⁃
[25] KOBLAN L W,DOMAN J L,WILSON C,et al. Improving throughput platform to identify small⁃molecule inhibitors
cytidine and adenine base editors by expression optimiza⁃ of CRISPR⁃Cas9[J]. Cell,2019,177(4):1067-1079
tion and ancestral reconstruction[J]. Nat Biotechnol, [41] GEISINGER J M,STEARNS T. CRISPR/Cas9 treatment
2018,36(9):843-846 causes extended TP53⁃dependent cell cycle arrest in hu⁃
[26] RICHTER M F,ZHAO K T,ETON E,et al. Phage⁃assisted man cells[J]. Nucleic Acids Res,2020,48(16):9067-
evolution of an adenine base editor with improved Cas do⁃ 9081
main compatibility and activity[J]. Nat Biotechnol,2020, [42] IHRY R J,WORRINGER K A,SALICK M R,et al. p53
38(7):883-891 inhibits CRISPR⁃Cas9 engineering in human pluripotent
[27] JIN S,ZONG Y,GAO Q,et al. Cytosine,but not adenine, stem cells[J]. Nat Med,2018,24(7):939-946
base editors induce genome⁃wide off⁃target mutations in [43] CHARLESWORTH C T,DESHPANDE P S,DEVER D P,
rice[J]. Science,2019,364(6437):292-295 et al. Identification of preexisting adaptive immunity to
[28] ZUO E,ZUO E,SUN Y,et al. Cytosine base editor gene⁃ Cas9 proteins in humans[J]. Nat Med,2019,25(2):249-
rates substantial off ⁃ target single ⁃ nucleotide variants in 254
mouse embryos[J]. Science,2019,364(6437):289-292 [44] KIM S,KOO T,JEE H G,et al. CRISPR RNAs trigger
[29] ZHOU C,SUN Y,YAN R,et al. Off⁃target RNA mutation innate immune responses in human cells[J]. Genome
induced by DNA base editing and its elimination by muta⁃ Res,2018,28(3):367-373
genesis[J]. Nature,2019,571(7764):275-278 [45] HENDEL A,BAK R O,CLARK J T,et al. Chemically
[30] MARINO N D,PINILLA⁃REDONDO R,CSÖRGO B,et modified guide RNAs enhance CRISPR⁃Cas genome edit⁃
al. Anti⁃CRISPR protein applications:natural brakes for ing in human primary cells[J]. Nat Biotechnol,2015,33
CRISPR ⁃ Cas technologies[J]. Nat Methods,2020,17 (9):985-989
(5):471-479 [46] MAGUIRE A M,SIMONELLI F,PIERCE E A,et al. Safety
[31] DONG,GUO M,WANG S,et al. Structural basis of CRISPR and efficacy of gene transfer for Leber’s congenital amau⁃
⁃SpyCas9 inhibition by an anti⁃CRISPR protein[J]. Na⁃ rosis[J]. N Engl J Med,2008,358(21):2240-2248
ture,2017,546(7658):436-439 [47] MENDELL J R,AL⁃ZAIDY S,SHELL R,et al. Single⁃
[32]JIANG F ,LIU J J ,OSUNA B A ,et al. Temperature⁃ dose gene⁃replacement therapy for spinal muscular atro⁃
responsive competitive inhibition of CRISPR ⁃ Cas9[J]. phy[J]. N Engl J Med,2017,377(18):1713-1722
Mol Cell,2019,73(3):601-610.e5 [48] CHEW W L,TABEBORDBAR M,CHENG J K,et al. A
[33] HARRINGTON L B,DOXZEN K W,MA E,et al. A broad multifunctional AAV⁃CRISPR⁃Cas9 and its host response
⁃spectrum inhibitor of CRISPR⁃cas9[J]. Cell,2017,170 [J]. Nat Methods,2016,13(10):868-874
(6):1224-1233.e15 [49] WU Z,YANG H,COLOSI P. Effect of genome size on
[34] SHIN J,JIANG F,LIU J J,et al. Disabling Cas9 by an anti AAV vector packaging[J]. Mol Ther,2010,18(1):80-86
⁃CRISPR DNA mimic[J]. Sci Adv,2017,3(7):e1701620 [50] KIM E,KOO T,PARK S W,et al. In vivo genome editing
[35] HEMPHILL J,BORCHARDT E K,BROWN K,et al. Op⁃ with a small Cas9 orthologue derived from Campylobacter
tical control of CRISPR/Cas9 gene editing[J]. J Am jejuni[J]. Nat Commun,2017,8:14500
Chem Soc,2015,137(17):5642-5645 [51] VERDERA H C,KURANDA K,MINGOZZI F. AAV vec⁃
[36] GAUTIER A,NGUYEN D P,LUSIC H,et al. Genetically tor immunogenicity in humans:a long journey to success⁃
encoded photocontrol of protein localization in mammalian ful gene transfer[J]. Mol Ther,2020,28(3):723-746
cells[J]. J Am Chem Soc,2010,132(12):4086-4088 [52] MAHESHRI N,KOERBER J T,KASPAR B K,et al. Di⁃
[37] NIHONGAKI Y,KAWANO F,NAKAJIMA T,et al. Pho⁃ rected evolution of adeno ⁃ associated virus yields en⁃
toactivatable CRISPR⁃Cas9 for optogenetic genome edit⁃ hanced gene delivery vectors[J]. Nat Biotechnol,2006,